The European Medicines Agency said on Tuesday that there was no new evidence that would require changes to the region’s current recommendations for the use of paracetamol, known as Tylenol in the United States, during pregnancy.
Related Posts
Blocking a single protein forces cancer cells to self-destruct: Study
Post Views: 7 When this protein, FSP1, was blocked, lung…
WHO says funding ‘dire’ for health emergencies in 2026
Post Views: 9 The WHO had identified more than 300…
IndiaAI, WHO announce global call for abstracts on scalable AI solutions in healthcare
Post Views: 23 “Shortlisted entries will be invited to contribute…